The effects of a hydrolyzed protein diet on the plasma, fecal and urine metabolome in cats with chronic enteropathy
The effects of a hydrolyzed protein diet on the plasma, fecal and urine metabolome in cats with chronic enteropathy
Hydrolyzed protein diets are extensively used to treat chronic enteropathy (CE) in cats. However, the biochemical effects of such a diet on feline CE have not been characterized. In this study an untargeted 1H nuclear magnetic resonance spectroscopy-based metabolomic approach was used to compare the urinary, plasma, and fecal metabolic phenotypes of cats with CE to control cats with no gastrointestinal signs recruited at the Royal Veterinary College (RVC). In addition, the biomolecular consequences of a hydrolyzed protein diet in cats with CE was also separately determined in cats recruited from the RVC (n = 16) and the University of Bristol (n = 24) and whether these responses differed between dietary responders and non-responders. Here, plasma metabolites related to energy and amino acid metabolism significantly varied between CE and control cats in the RVC cohort. The hydrolyzed protein diet modulated the urinary metabolome of cats with CE (p = 0.005) in both the RVC and Bristol cohort. In the RVC cohort, the urinary excretion of phenylacetylglutamine, p-cresyl-sulfate, creatinine and taurine at diagnosis was predictive of dietary response (p = 0.025) although this was not observed in the Bristol cohort. Conversely, in the Bristol cohort plasma betaine, glycerol, glutamine and alanine at diagnosis was predictive of outcome (p = 0.001), but these same results were not observed in the RVC cohort. The biochemical signature of feline CE in the RVC cohort was consistent with that identified in human and animal models of inflammatory bowel disease. The hydrolyzed protein diet had the same effect on the urinary metabolome of cats with CE at both sites. However, biomarkers that were predictive of dietary response at diagnosis differed between the 2 sites. This may be due to differences in disease severity, disease heterogeneity, factors unrelated to the disease or small sample size at both sites. As such, further studies utilizing larger number of cats are needed to corroborate these findings.
Kathrani, Aarti
dc909987-b3d4-42cf-8270-59c77625942c
Yen, Sandi
c30f3c56-26a5-43eb-9fce-592583587558
Hall, Edward J.
febbd74f-0b34-4eab-923d-08e6c8cfa44f
Swann, Jonathan R.
7c11a66b-f4b8-4dbf-aa17-ad8b0561b85c
December 2023
Kathrani, Aarti
dc909987-b3d4-42cf-8270-59c77625942c
Yen, Sandi
c30f3c56-26a5-43eb-9fce-592583587558
Hall, Edward J.
febbd74f-0b34-4eab-923d-08e6c8cfa44f
Swann, Jonathan R.
7c11a66b-f4b8-4dbf-aa17-ad8b0561b85c
Kathrani, Aarti, Yen, Sandi, Hall, Edward J. and Swann, Jonathan R.
(2023)
The effects of a hydrolyzed protein diet on the plasma, fecal and urine metabolome in cats with chronic enteropathy.
Scientific Reports, 13 (1), [19979].
(doi:10.1038/s41598-023-47334-y).
Abstract
Hydrolyzed protein diets are extensively used to treat chronic enteropathy (CE) in cats. However, the biochemical effects of such a diet on feline CE have not been characterized. In this study an untargeted 1H nuclear magnetic resonance spectroscopy-based metabolomic approach was used to compare the urinary, plasma, and fecal metabolic phenotypes of cats with CE to control cats with no gastrointestinal signs recruited at the Royal Veterinary College (RVC). In addition, the biomolecular consequences of a hydrolyzed protein diet in cats with CE was also separately determined in cats recruited from the RVC (n = 16) and the University of Bristol (n = 24) and whether these responses differed between dietary responders and non-responders. Here, plasma metabolites related to energy and amino acid metabolism significantly varied between CE and control cats in the RVC cohort. The hydrolyzed protein diet modulated the urinary metabolome of cats with CE (p = 0.005) in both the RVC and Bristol cohort. In the RVC cohort, the urinary excretion of phenylacetylglutamine, p-cresyl-sulfate, creatinine and taurine at diagnosis was predictive of dietary response (p = 0.025) although this was not observed in the Bristol cohort. Conversely, in the Bristol cohort plasma betaine, glycerol, glutamine and alanine at diagnosis was predictive of outcome (p = 0.001), but these same results were not observed in the RVC cohort. The biochemical signature of feline CE in the RVC cohort was consistent with that identified in human and animal models of inflammatory bowel disease. The hydrolyzed protein diet had the same effect on the urinary metabolome of cats with CE at both sites. However, biomarkers that were predictive of dietary response at diagnosis differed between the 2 sites. This may be due to differences in disease severity, disease heterogeneity, factors unrelated to the disease or small sample size at both sites. As such, further studies utilizing larger number of cats are needed to corroborate these findings.
Text
s41598-023-47334-y
- Version of Record
More information
Accepted/In Press date: 12 November 2023
e-pub ahead of print date: 15 November 2023
Published date: December 2023
Additional Information:
Publisher Copyright:
© 2023, The Author(s).
Identifiers
Local EPrints ID: 494316
URI: http://eprints.soton.ac.uk/id/eprint/494316
ISSN: 2045-2322
PURE UUID: 2b640474-b0c7-45ac-a40f-82d42f14da77
Catalogue record
Date deposited: 03 Oct 2024 16:43
Last modified: 05 Oct 2024 02:05
Export record
Altmetrics
Contributors
Author:
Aarti Kathrani
Author:
Sandi Yen
Author:
Edward J. Hall
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics